Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. The company develops cell-targeted lipid nanoparticle (ctLNP) platform, a modular delivery system for nucleic acids to avoid off-target clearance by the liver and spleen that enables ctLNPs to persist in systemic circulation, which allows for highly selective and potent ligand-driven targeting to specific tissues and cell types; and novel immune-quiet DNA (iqDNA) to enable long-lasting high levels of gene expression from non-integrating episomes and avoids innate immune sensors that have long prevented DNA from use in non-viral systems. It uses its platform for developing a portfolio of programs for treating cancer, autoimmune, hematologic disorders, prioritizing sickle cell, beta-thalassemia, and hemophilia A diseases, as well as for other tissues and cell types, including retina, skeletal muscle, and central nervous system. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. more
Time Frame | GBIO | Sector | S&P500 |
---|---|---|---|
1-Week Return | -19.69% | -2.06% | -0.55% |
1-Month Return | -28.67% | -1.92% | 2.72% |
3-Month Return | -60.62% | -10.4% | 7.66% |
6-Month Return | -62.22% | -4.6% | 10.15% |
1-Year Return | -46.6% | 4.06% | 27.53% |
3-Year Return | -86.4% | 1.94% | 32.31% |
5-Year Return | -95.87% | 36.48% | 89.2% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | 880.00K | 5.90M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":14.91,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 1.86M | 3.43M | 4.53M | 5.13M | 79.81M | [{"date":"2019-12-31","value":2.34,"profit":true},{"date":"2020-12-31","value":4.3,"profit":true},{"date":"2021-12-31","value":5.68,"profit":true},{"date":"2022-12-31","value":6.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (1.86M) | (3.43M) | (4.53M) | (5.13M) | (73.91M) | [{"date":"2019-12-31","value":-186400000,"profit":false},{"date":"2020-12-31","value":-343200000,"profit":false},{"date":"2021-12-31","value":-453200000,"profit":false},{"date":"2022-12-31","value":-513000000,"profit":false},{"date":"2023-12-31","value":-7391100000,"profit":false}] |
Gross Margin | - | - | - | (582.95%) | (1251.88%) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-582.95,"profit":false},{"date":"2023-12-31","value":-1251.88,"profit":false}] |
Operating Expenses | 62.30M | 81.11M | 119.10M | 141.18M | 144.47M | [{"date":"2019-12-31","value":43.13,"profit":true},{"date":"2020-12-31","value":56.15,"profit":true},{"date":"2021-12-31","value":82.44,"profit":true},{"date":"2022-12-31","value":97.73,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (62.30M) | (81.11M) | (119.10M) | (141.18M) | (138.56M) | [{"date":"2019-12-31","value":-6230200000,"profit":false},{"date":"2020-12-31","value":-8111400000,"profit":false},{"date":"2021-12-31","value":-11910100000,"profit":false},{"date":"2022-12-31","value":-14118200000,"profit":false},{"date":"2023-12-31","value":-13856300000,"profit":false}] |
Total Non-Operating Income/Expense | 1.97M | 1.18M | (100.00K) | 9.09M | 23.90M | [{"date":"2019-12-31","value":8.24,"profit":true},{"date":"2020-12-31","value":4.95,"profit":true},{"date":"2021-12-31","value":-0.42,"profit":false},{"date":"2022-12-31","value":38.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (61.32M) | (80.52M) | (119.15M) | (136.64M) | (126.61M) | [{"date":"2019-12-31","value":-6131700000,"profit":false},{"date":"2020-12-31","value":-8052300000,"profit":false},{"date":"2021-12-31","value":-11915100000,"profit":false},{"date":"2022-12-31","value":-13663900000,"profit":false},{"date":"2023-12-31","value":-12661200000,"profit":false}] |
Income Taxes | (985.00K) | (4.02M) | (4.48M) | (4.54M) | 5.10M | [{"date":"2019-12-31","value":-19.33,"profit":false},{"date":"2020-12-31","value":-78.96,"profit":false},{"date":"2021-12-31","value":-87.97,"profit":false},{"date":"2022-12-31","value":-89.16,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (60.33M) | (76.50M) | (114.67M) | (132.10M) | (131.71M) | [{"date":"2019-12-31","value":-6033200000,"profit":false},{"date":"2020-12-31","value":-7650000000,"profit":false},{"date":"2021-12-31","value":-11466900000,"profit":false},{"date":"2022-12-31","value":-13209600000,"profit":false},{"date":"2023-12-31","value":-13170710500,"profit":false}] |
Income From Continuous Operations | (61.32M) | (80.52M) | (119.15M) | (136.64M) | (126.61M) | [{"date":"2019-12-31","value":-6131700000,"profit":false},{"date":"2020-12-31","value":-8052300000,"profit":false},{"date":"2021-12-31","value":-11915100000,"profit":false},{"date":"2022-12-31","value":-13663900000,"profit":false},{"date":"2023-12-31","value":-12661200000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (60.33M) | (76.50M) | (114.67M) | (132.10M) | (126.61M) | [{"date":"2019-12-31","value":-6033200000,"profit":false},{"date":"2020-12-31","value":-7650000000,"profit":false},{"date":"2021-12-31","value":-11466900000,"profit":false},{"date":"2022-12-31","value":-13209600000,"profit":false},{"date":"2023-12-31","value":-12661200000,"profit":false}] |
EPS (Diluted) | - | (3.29) | (2.11) | (2.35) | (1.96) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-329,"profit":false},{"date":"2021-12-31","value":-211,"profit":false},{"date":"2022-12-31","value":-235,"profit":false},{"date":"2023-12-31","value":-196,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
GBIO | |
---|---|
Cash Ratio | 6.13 |
Current Ratio | 6.34 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
GBIO | |
---|---|
ROA (LTM) | -19.29% |
ROE (LTM) | -86.50% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
GBIO | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.58 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.42 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
GBIO | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 3.92 |
P/B | 0.74 |
Price/FCF | NM |
EV/R | 5.10 |
EV/Ebitda | NM |
Generation Bio Co (GBIO) share price today is $1.02
Yes, Indians can buy shares of Generation Bio Co (GBIO) on Vested. To buy Generation Bio Co from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GBIO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Generation Bio Co (GBIO) via the Vested app. You can start investing in Generation Bio Co (GBIO) with a minimum investment of $1.
You can invest in shares of Generation Bio Co (GBIO) via Vested in three simple steps:
The 52-week high price of Generation Bio Co (GBIO) is $4.65. The 52-week low price of Generation Bio Co (GBIO) is $0.75.
The price-to-earnings (P/E) ratio of Generation Bio Co (GBIO) is
The price-to-book (P/B) ratio of Generation Bio Co (GBIO) is 0.74
The dividend yield of Generation Bio Co (GBIO) is 0.00%
The market capitalization of Generation Bio Co (GBIO) is $72.80M
The stock symbol (or ticker) of Generation Bio Co is GBIO